Preliminary scientific studies point out conolidine could inhibit particular ion channels, lowering neuronal excitability and restricting pain signals. This system is especially pertinent in neuropathic pain, where irregular signaling results in persistent soreness. On top of that, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to discomfort https://johnd246kif5.mybuzzblog.com/profile